Table 1 Patients characteristics.
Patients (N = 69) | Patients with Vit. D-w1 (N = 52) | Patients with IgG-w4 (N = 67) | ||
|---|---|---|---|---|
Sex N (%) | Female | 37 (53.6) | 26 (50.0) | 37 (55.2) |
Male | 32 (46.4) | 26 (50.0) | 30 (44.8) | |
Age | Median (IQR) | 59.00 (44.50–67.00) | 62.00 (51.50–70.00) | 59.00 (44.00–67.00) |
Hospitalisation N (%) | Yes | 42 (60.9) | 39 (75.0) | 40 (59.7) |
Disease severity N (%) | Mild | 16 (23.2) | 8 (15.4) | 16 (23.9) |
Moderate | 24 (34.8) | 18 (34.6) | 24 (35.8) | |
Severe | 25 (36.2) | 22 (42.3) | 25 (37.3) | |
Critical | 4 (5.8) | 4 (7.7) | 2 (3.0) | |
Comorbidities N (%) | Hypertension | 27 (39.1) | 22 (42.3) | 27 (40.3) |
Diabetes Mellitus | 10 (14.5) | 9 (17.3) | 10 (14.9) | |
Cancer | 5 (7.2) | 5 (9.6) | 4 (6.0) | |
Hypothyreosis | 4 (5.8) | 2 (3.9) | 4 (6.0) | |
Outcome N (%) | Recovery | 65 (94.2) | 48 (92.3) | 65 (97.0) |
Death | 4 (5.8) | 4 (7.7) | 2 (3.0) | |
Medications used during illness N (%) | Corticosteroids | 49 (71.0) | 43 (82.7) | 47 (70.1) |
Antivirals | 29 (42.0) | 25 (48.1) | 28 (41.8) | |
Antibiotics | 65 (94.2) | 51 (98.1) | 64 (95.5) | |
Vit. D Groups N (%) | Deficient (≤ 20) | 17 (32.7) | 15 (22.4) | |
Insufficent (21–29) | 17 (32.7) | 17 (25.4) | ||
Sufficient (≥ 30) | 18 (34.6) | 18 (26.9) |
